Dr. Denise Yardley discusses the latest cancer drug approved by the FDA for advanced, metastatic, HER2+ breast cancer: Kadcyla or T-DM1. Kadclya is a first time in class drug for breast cancer that acts as a targeted therapy.
Created on February 28, 2013
Last updated on May 28, 2014
Source: Denise A. Yardley, M.D.